President’s address: Toward optimization of the treatment of patients with Breast Cancer Tomoo Tajima OriginalPaper Pages: 262 - 268
Taking the battle against breast cancer across borders: Consumers, advocates, and change Susan G. Braun Special Lecture III Pages: 269 - 272
Breast conservation therapy (BCT): Surgery as the cornerstone of multi-specialty care Benjamin O. Anderson Special Program II Pages: 273 - 275
Oncoplastic techniques in the conservative surgical treatment of Breast Cancer Riccardo MasettiPasquale G. PirulliArmando Antinori Special Program II Pages: 276 - 280
Optimal management of the axilla in patients with Breast Cancer Eisei ShinYukiko MinamiToshimasa Tsujinaka Symposium I Pages: 281 - 283
Sentinel lymph node biopsy using tin colloid Rl and blue dye method Tadashi IkedaShigeru MasamuraMasaki Kitajima Symposium I Pages: 284 - 286
Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization Masakuni NoguchiKoichiro TsugawaTakao Taniya Symposium I Pages: 287 - 296
Predictive factors for response to endocrine therapy in patients with recurrent Breast Cancer Hiroshi SonooJunichi Kurebayashi Symposium II Pages: 297 - 301
High dose chemotherapy as adjuvant treatment in operable Breast Cancer with 10 or more involved axillary lymph nodes Eiichi ShibaKenji AkazawaShinzaburo Noguchi Panel Discussion I Pages: 302 - 306
Bisphosphonate therapy for bone metastases from Breast Cancer: Clinical results and a new therapeutic approach Shoji OuraHirokazu TaninoYasuaki Naito Panel Discussion I Pages: 307 - 310
The predictive value of angiogenesis for adjuvant therapy in Breast Cancer Masakazu ToiHiroko BandoKatsumasa Kuroi Panel Discussion I Pages: 311 - 314
Ductal intraepithelial neoplasia (Idh, aidh and dcis) Fattaneh A. Tavassoli Panel Discussion II Pages: 315 - 320
A proposal for the histopathological diagnosis of ductal carcinoma in situ of the Breast Takuya MoriyaMasako KasamiNoriaki Ohuchi Panel Discussion II Pages: 321 - 325
Atypical cystic lobule of the breast: An early stage of low-grade ductal carcinomain-situ Tetsunari OyamaKotaro lijimaFrederick Koerner Panel Discussion II Pages: 326 - 331
Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in Situ Hybridization (FISH) analysis Yoshifumi KomoikeKazuyoshi MotomuraHiroki Koyama Panel Discussion II Pages: 332 - 336
Surgery for ductal carcinoma in Situ Kaoru TakahashiMitsue SaitoGoi Sakamoto Panel Discussion II Pages: 337 - 340
Treatment of noninvasive carcinoma: Fifteen-Year results at the National Cancer Center Hospital in Tokyo Sadako Akashi-TanakaTakashi FukutomiHitoshi Tsuda Panel Discussion II Pages: 341 - 344
Endocrine options for Breast Cancer treatment: Looking beyond Tamoxifen Toru WatanabeHiroshi Sonoo Satellite Symposium I Pages: 345 - 349
New molecule-targeting therapy with Herceptin (Trastuzumab), an anti-HER2 (c-erB-2) monoclonal antibody Goi SakamotoShoshu Mitsuyama Satellite Symposium II Pages: 350 - 357
Adjuvant chemotherapy for early Breast Cancer Yuichi TakatsukaTakeshi Tominaga Satellite Symposium III Pages: 358 - 360
Optimising treatment of bone metastases by Aredia™ and Zometa™ Robert E. Coleman Luncheon Seminar II Pages: 361 - 369
State of the art of minimally invasive breast biopsy: Principles and practice Hernan I. VargasRodolfo V. AgbunagIraj Khalkhali Luncheon Seminar III Pages: 370 - 379
Current perspectives for treatment of Breast Cancer Craig Bunnell Luncheon Seminar VI Pages: 380 - 388
Sentinel lymph node biopsy for breast cancer: Combined dye-isotope technique Charles E. CoxChristopher SaludDouglas S. Reintgen Morning Session II Pages: 389 - 397
